Aslan Pharmaceuticals Pte. Ltd. Product Pipeline Review – 2015

1
Aslan Pharmaceuticals Pte. Ltd. Product Pipeline
Review - 2015
Published on October - 2015
2
.
Report Overview
About Aslan Pharmaceuticals Pte. Ltd. Product
Pipeline Review - 2015 Global Markets Directs,
Aslan Pharmaceuticals Pte. Ltd. Product Pipeline
Review - 2015, provides an overview of the Aslan
Pharmaceuticals Pte. Ltd. s pharmaceutical
research and development focus. This report
provides comprehensive information on the current
therapeutic developmental pipeline of Aslan
Pharmaceuticals Pte. Ltd. s, complete with
comparative analysis at various stages,
therapeutics assessment by drug target, mechanism
of action (MoA), route of administration (RoA)
and molecule type. It also reviews latest
updates, and featured news and press releases,
along with special features on late-stage and
discontinued projects. Global Markets Directs
report features investigational drugs from across
globe covering over 20 therapy areas and nearly
3,000 indications. The report is built using data
and information sourced from Global Markets
Directs proprietary data bases,
Company/University websites, SEC filings,
investor presentations and featured press
releases from company/university sites and
industry-specific third party sources, put
together by Global Markets Directs team. Get
Full Details On http//www.researchbeam.com/asla
n-pharmaceuticals-pte-ltd-product-pipeline-review-
2015-market
3
.
Report Overview
Drug profiles/records featured in the report
undergoes periodic updation following a stringent
set of processes that ensures that all the
profiles are updated with the latest set of
information. Additionally, processes including
live news deals tracking, browser based
alert-box and clinical trials registries tracking
ensure that the most recent developments are
captured on a real time basis. The report
enhances decision making capabilities and help to
create effective counter strategies to gain
competitive advantage. It strengthens RD
pipelines by identifying new targets and MOAs to
produce first-in-class and best-in-class
products. Note Certain sections in the report
may be removed or altered based on the
availability and relevance of data for the
indicated disease. Scope The report provides
brief overview of Aslan Pharmaceuticals Pte. Ltd.
including business description, key information
and facts, and its locations and subsidiaries The
report reviews current pipeline of Aslan
Pharmaceuticals Pte. Ltd. s human therapeutic
division and enlists all their major and minor
projects
4
.
Report Overview
The report features product description and
descriptive mechanism of action for key pipeline
products along with the products developmental
history and major milestones Special feature on
out-licensed and partnered product portfolio The
report summarizes all the dormant and
discontinued pipeline projects Latest company
statement Latest news and deals relating to the
Aslan Pharmaceuticals Pte. Ltd. s pipeline
products   Reasons to buy Evaluate Aslan
Pharmaceuticals Pte. Ltd. s strategic position
with total access to detailed information on its
product pipeline Assess the growth potential of
Aslan Pharmaceuticals Pte. Ltd. in its therapy
areas of focus Identify new drug targets and
therapeutic classes in the Aslan Pharmaceuticals
Pte. Ltd. s RD portfolio and develop key
strategic initiatives to reinforce pipeline in
those areas Exploit in-licensing opportunities by
identifying windows of opportunity to fill
portfolio gaps
5
Report Overview

• Develop strategic initiatives by understanding
  the focus areas of Aslan Pharmaceuticals Pte.
  Ltd. and exploit collaboration and partnership
  opportunities
• Identify emerging players with potentially strong
  product portfolio and create effective
  counter-strategies to gain competitive advantage
• Plan mergers and acquisitions effectively by
  identifying the most promising pipeline of Aslan
  Pharmaceuticals Pte. Ltd.
• Develop and design in-licensing and out-licensing
  strategies by identifying prospective partners
  with the most attractive projects to enhance and
  expand business potential and Scope
• Explore the dormant and discontinued projects of
  Aslan Pharmaceuticals Pte. Ltd. and identify
  potential opportunities in those areas
• Avoid Intellectual Property Rights related issues

6
Table Of Contents
List of Tables 4List of Figures 4Aslan
Pharmaceuticals Pte. Ltd. Snapshot 5Aslan
Pharmaceuticals Pte. Ltd. Overview 5Key
Information 5Key Facts 5Aslan Pharmaceuticals
Pte. Ltd. - Research and Development Overview
6Key Therapeutic Areas 6Aslan Pharmaceuticals
Pte. Ltd. - Pipeline Review 8Pipeline Products
by Stage of Development 8Pipeline Products -
Monotherapy 9Pipeline Products - Partnered
Products 10Partnered Products/Combination
Treatment Modalities 11Aslan Pharmaceuticals
Pte. Ltd. - Pipeline Products Glance 12
7
Table Of Contents
Aslan Pharmaceuticals Pte. Ltd. - Clinical Stage
Pipeline Products 12Phase II Products/Combination
Treatment Modalities 12Phase I
Products/Combination Treatment Modalities
13Aslan Pharmaceuticals Pte. Ltd. - Early Stage
Pipeline Products 14Preclinical
Products/Combination Treatment Modalities
14Aslan Pharmaceuticals Pte. Ltd. - Drug
Profiles 15varlitinib 15Product Description
15Mechanism of Action 15RD Progress
15ASLAN-003 18Product Description 18Mechanism
of Action 18RD Progress 18
8
Table Of Contents
BMS-777607 19Product Description 19Mechanism of
Action 19RD Progress 19ASLAN-004 20Product
Description 20Mechanism of Action 20RD
Progress 20 Aslan Pharmaceuticals Pte. Ltd. -
Pipeline Analysis 21Aslan Pharmaceuticals Pte.
Ltd. - Pipeline Products by Target 21Aslan
Pharmaceuticals Pte. Ltd. - Pipeline Products by
Route of Administration 22 Enquiry about this
report _at_ http//www.researchbeam.com/aslan-pharmac
euticals-pte-ltd-product-pipeline-review-2015-mark
et/enquire-about-report
9
FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/aslan-pharmaceuticals-
pte-ltd-product-pipeline-review-2015-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone] E-MAIL
sales_at_researchbeam.com